Healthcare investment fund founded:
This article was originally published in Clinica
Executive Summary
Henry Wendt, the retired SmithKline Beecham chairman who piloted its 1989 merger, is one of a line-up of healthcare managers who have set up the Finisterre fund, a private equity investment fund working exclusively in the healthcare products industry. Finisterre intends to acquire "foundation" companies and then to build each of them through strategic acquisition of related companies and products. By "foundation" company the group means one with at least $50 million in revenue, with operating profits and products essential to patient health. The fund says it can make large acquisitions of up to $1,000 million.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.